MarketInOut Stock Screener Log In | Sign Up

Alembic Pharmaceuticals Ltd

BSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/27/2026 15:56
Alembic Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeBSE
Market Capitalization148,985 mln
Float58.33 mln

EPS

35.27
Exceptional

P / E

21.86
Premium valuation

Piotroski F-Score

6 / 9
Solid

Beneish M-Score

-2.16
Caution advised

1-Year Forecast

961.80
Attractive

Relative Strength

61 / 100
Outperforming

Business Description

Founded over a century ago and based in Vadodara, India, Alembic Pharmaceuticals produces and sells a wide range of medicines both domestically and abroad. Its offerings span numerous health conditions, from heart disease and diabetes to eye care and infections, as well as treatments for animals. The company also supplies raw pharmaceutical ingredients to other manufacturers.

Key Fundamentals

EPS35.27
P/E21.86
ROE12.78
RPS396
ROIC10.71
ROA8.26
Interest Cover8.46
EBITDA, mln11,648
EV / EBITDA15.56
EV / EBIT22.04
Revenue, mln77,840
EV / Revenue2.33

Quote Details

Last 770.95
Change 4.3 (0.56%)
Open 761.05
Volume 5,536
Turnover 4,267,980
Average Volume 12,812

Financial Ratios

Pre-Tax Profit Margin9
Current Ratio1.80
Price / Book2.83
Price / Tangible Book2.98
Price / Cash Flow37.32
Price / Free Cash Flow62.30
Debt / Equity0.25
Price / Sales2.08

Financial Strength

Altman Z-Score5.49
Piotroski F-Score 6 / 9
Beneish M-Score-2.16
Price to Intrinsic Value2.87
Price to Graham Number1.73
1-Year Target Price961.80
Shiller PE Ratio21.27

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -2.58% 56 / 100   
1 Month -9.3% 40 / 100   
2 Months -7.8% 50 / 100   
6 Months 4.31% 68 / 100   
1 Year -16.03% 53 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog